North Haven Alternatives Insurance Fund C Series of the SALI Multi-Series Fund, L.P. has sold $125,924,435 through an indefinite exempt securities offering. Investors receive a disclosed sales amount without a stated dollar limit for the offering, while a separate A Series notice lists $154,652,183 sold.
Key Highlights
- The filing reports $125,924,435 sold in the C Series offering.
- The offering amount is listed as indefinite.
- The issuer is a Delaware limited Partnership classified as a pooled Investment fund and other investment fund.
North Haven Alternatives Insurance Fund C Series of the SALI Multi-Series Fund, L.P. has sold $125,924,435 through an indefinite exempt securities offering. The amount identifies securities sold to date, while the filing reports the offering amount as indefinite.
C Series Offering Details
Its listed address is 6850 Austin Center Boulevard, Suite 300, Austin, Texas 78,731. Cameron J. Vail signed the filing as Managing Director of the General Partner on September 10, 2026. The filing lists 25 April 2025 in the reported transaction details. FAS Corp. is listed in connection with the offering, with an address at 4747 West 135th Street, Suite 100, Leawood, Kansas 66,224.
FAQs
Q: How much has North Haven C Series sold in its exempt offering?
A: North Haven Alternatives Insurance Fund C Series has sold $125,924,435 in its indefinite exempt securities offering. The disclosed amount refers to securities sold.
Q: What does the North Haven C Series offering notice show?
A: The notice identifies an indefinite exempt securities offering for the C Series. It reports that $125,924,435 had been sold in the offering.
Q: What organizational details does the filing provide?
A: The filing identifies the C Series as a Delaware limited partnership and a pooled investment fund classified as an other investment fund. It lists an Austin, Texas address.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.